1Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline [J]. J Clin Endocrinol Metab, 2008,93 : 3266-3281.
2Morillas P, Castillo J, Quiles J, et al. Prevalence of primary aldo steronism in hypertensive patients and its effect on the heart[J]. Rev Esp Cardiol,2008,61:418 -421.
3Adler G, Willimas G. Aldosterone: villain or protector[J]. Hypertension, 2007,50 : 31-32.
4Ruilope LM. Aldosterone, hypertension, and cardiovascular disease : an endless story[J]. Hypertension, 2008,52 : 207-208.
6Fischer P, Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: the gp130 STAT3 axis[J]. Basic Res Cardiol, 2007,102:279- 297.
7Tsai CT, Lai LP, Kuo KT, et al. Angiotensin II activates signal transducer and activators of transcription 3 via Rael in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling[J]. Circulation, 2008,117 : 344- 355.
8Hilfiker-Kleiner D, Knoll R. Disease-modifying mutations in familial hypertrophic cardiomyopathy: complexity from simplicity [J]. Circulation, 2008,117 : 1775-1777.
